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Hypophosphatemia occurs in 40 to 60% of patients with acute malaria, and in many other conditions associated with
elevations of body temperature. To determine the prevalence and causes of hypophosphatemia in patients with malaria, we
retrospectively studied all adults diagnosed with acute malaria during a 12-year period. To validate our findings, we analyzed a
second sample of malaria patients during a subsequent 10-year period. Serum phosphorus correlated inversely with
temperature (n=59, r=20.62; P,0.0001), such that each 1uC increase in body temperature was associated with a reduction of
0.18 mmol/L (0.56 mg/dL) in the serum phosphorus level (95% confidence interval: 20.12 to 20.24 mmol/L [20.37 to
20.74 mg/dL] per 1uC). A similar effect was observed among 19 patients who had repeat measurements of serum phosphorus
and temperature. In a multiple linear regression analysis, the relation between temperature and serum phosphorus level was
independent of blood pH, PCO2, and serum levels of potassium, bicarbonate, calcium, albumin, and glucose. Our study
demonstrates a strong inverse linear relation between body temperature and serum phosphorus level that was not explained
by other factors known to cause hypophosphatemia. If causal, this association can account for the high prevalence of
hypophosphatemia, observed in our patients and in previous studies of patients with malaria. Because hypophosphatemia has
been observed in other clinical conditions characterized by fever or hyperthermia, this relation may not be unique to malaria.
Elevation of body temperature should be added to the list of causes of hypophosphatemia.
Citation: Browner W, Haber R (2007) Fever as a Cause of Hypophosphatemia in Patients with Malaria. PLoS ONE 2(12): e1380. doi:10.1371/
journal.pone.0001380
INTRODUCTION
Low serum phosphorus levels (,0.81 mmol/L [2.5 mg/dL]) are
common in hospitalized patients [1]. When combined with
chronic phosphate depletion, hypophosphatemia can result in
serious neurologic, cardiopulmonary, musculoskeletal, hematolo-
gical, and metabolic dysfunction [1–3].
Although hypophosphatemia may occur in 40–60% of patients
with acute malaria [4–6], its pathogenesis in this setting is not
known. To determine the prevalence and causes of hypophos-
phatemia in patients with malaria, we retrospectively studied all
adults diagnosed with acute malaria during a 12-year period. To
validate our findings, we analyzed a second sample of malaria
patients during a subsequent 10-year period.
METHODS
Objectives
We sought to determine the correlation between body temperature
and serum phosphorus level in patients with malaria, and to see
whether that correlation was affected by adjustment for potential
confounding variables, such as serum albumin or bicarbonate
levels. We also determined whether changes in body temperature
correlated with changes in serum phosphorus levels.
Participants
Medical records of all patients 18 years of age or greater
presenting to San Francisco General Hospital with acute malaria
between 1976 and 1987 were reviewed. These dates were chosen
because serum phosphorus (measured as phosphate, PO4) was
included in the automated multichannel ‘‘metabolic’’ panel during
that time. Patients were identified through medical records
discharge diagnoses (ICD code 0.84.0-0.84.9) and the parasitology
laboratory log. To validate the relation between body temperature
and serum phosphorus observed in the first sample, data from a
second group of patients who presented to San Francisco General
Hospital and the University of California, San Francisco Moffitt-
Long Hospitals during an additional 10-year period (1988–1997)
were analyzed.
Description of Procedures
We abstracted demographic and clinical information at presentation
from the medical records, with particular attention to conditions
associated with hypophosphatemia. Initial temperature and labora-
tory values (including serum levels of phosphorus, calcium,
potassium, bicarbonate, glucose, albumin, creatinine, indirect
bilirubin, aspartate aminotransferase and lactate dehydrogenase; a
complete blood count with differential; and arterial blood gas values)
were recorded; we verified that the samples had been obtained prior
to initiation of any therapy. We also recorded subsequent ‘‘dyads’’ of
body temperature and serum phosphorus levels if available; we
required that the temperature have been recorded within four hours
of the time that the serum sample was obtained.
Academic Editor: Nicholas White, Mahidol University, Thailand
Received May 24, 2007; Accepted December 12, 2007; Published December 26,
2007
Copyright:  2007 Haber, Browner. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Funding: The authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests
exist.
* To whom correspondence should be addressed. E-mail: warren@cpmcri.org
{ Deceased.
PLoS ONE | www.plosone.org 1 December 2007 | Issue 12 | e1380Ethics
The study was approved by the University of California, San
Francisco Committee on Human Research; informed consent was
not required. No external funds were used to support this study.
Statistical methods
We compared patients with low and normal phosphorus levels
using chi-squared and Student’s t tests, as appropriate. Simple and
multivariate linear regression models were used to determine the
correlations between serum phosphorus levels (and changes in
serum phosphorus levels) and other continuous variables,
including arterial pH and PCO2 (since respiratory alkalosis can
cause hypophosphatemia) [1,2,7]. Statistical significance was
defined as P,0.05 (two-sided). All analyses were performed using
StatCrunch software (www.statcrunch.com).
RESULTS
Of the 76 adult patients who presented to San Francisco General
Hospital with acute malaria in the initial 12-year period, 59 (78%)
patients had serum phosphorus levels available for analysis, of
whom 35 (59%) had low levels (,0.81 mmol/L [2.5 mg/dL]),
including 5 (8%) with severe hypophosphatemia (,0.32 mmol/L
[1.0 mg/dL ]). Patients with low serum phosphorus levels on
admission had a significantly greater mean body temperature than
those with normal levels (Table 1), and all 13 patients with
temperatures $40.2uC had hypophosphatemia (Figure 1). There
were also marginally significant differences in mean serum
potassium and bicarbonate levels in those with and without
hypophosphatemia (Table 1).
Serum phosphorus correlated inversely with temperature
(Figure 1, r=20.62; P,0.0001), such that each 1uC increase in
body temperature was associated with a reduction of 0.18 mmol/
L [0.56 mg/dL] in the serum phosphorus level (95% confidence
interval: 20.12 to 20.24 mmol/L [20.37 to 20.74 mg/dL] per
uC). In a multiple linear regression analysis, the relation between
temperature and serum phosphorus was independent of serum
levels of potassium, bicarbonate, calcium, albumin, and glucose
(multivariate R
2=0.48, P,0.0001 for temperature, all P$0.32 for
the other 5 variables).
Body temperature and serum phosphorus levels were available
on two occasions in 19 patients. The correlation between the
change in temperature and the change in serum phosphorus level
was highly significant (Figure 2, r=20.66, P,0.002). Each 1uC
fall in body temperature was associated with a 0.16 mmol/L
Figure 1. There was a highly significant correlation (r=20.62,
P,0.0001) between serum phosphorus level and temperature in
59 patients with malaria. Each 1uC increase in temperature was
associated with a reduction in serum phosphorus level of 0.18 mmol/L
[0.56 mg/dL].
doi:10.1371/journal.pone.0001380.g001
Table 1. Characteristics of the 59 subjects in the San Francisco General Hospital sample, stratified by serum phosphorus level.
..................................................................................................................................................
Characteristic
Hypophosphatemia
(,0.81 mmol/L [2.5 mg/dL]) (n=37) Normal phosphorus (n=22) P value
N (%) or Mean6SD
Female sex 10 (27) 9 (41) 0.41
Age (years) 31615 29610 0.44
Origin of malaria (Central America, India, SE Asia, Africa) 14 (38), 8 (22), 11 (30), 4 (11) 9 (41), 5 (23), 8 (36), 0 (0) 0.42
Plasmodium vivax 34 (92) 22 (100) 0.45
Temperature (uC) 39.761.0 38.561.0 ,0.0001
Hemoglobin (g/L) 135626 130620 0.26
Glucose (mmol/L) 6.4461.72 6.3861.72 0.85
Potassium (mmol/L) 3.660.3 3.860.3 0.05
Bicarbonate (mmol/L) 22.862.4 23.962.9 0.05
Creatinine (umol/L) 97618 88618 0.26
Calcium (mmol/L) 2.260.1 2.260.2 0.96
Albumin (g/L) 39643 9 64 0.93
Indirect bilirubin (mol/L) 24612 21610 0.46
Aspartate aminotransferase (U/L) 31627 24616 0.28
Lactate dehydrogenase (U/L) 239665 257697 0.41
pH* 7.4460.04 7.4660.03 0.28
PCO2 (mm Hg)* 32.662.8 34.263.5 0.19
*Arterial blood gas values were available for 17 patients, including 11 with hypophosphatemia.
doi:10.1371/journal.pone.0001380.t001
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PLoS ONE | www.plosone.org 2 December 2007 | Issue 12 | e1380[0.51 mg/dL] (95% confidence interval: 0.07 to 0.26 mmol/L
[0.23 to 0.79 mg/dL] per uC) increase in the serum phosphorus
level. These changes occurred as rapidly as within four hours
without specific phosphate replacement.
Arterial blood gas determinations were made in 17 patients
(Table 1). There were no significant correlations between serum
phosphorus levels and pH, PCO2, or bicarbonate levels (all
P$0.11). The inverse correlation between body temperature and
serum phosphorus remained significant in this smaller group of
patients even after adjusting for those measurements (r
2=0.49,
P,0.02).
Validation sample
We analyzed a second sample of 121 patients presenting to San
Francisco General Hospital and UCSF Moffitt-Long Hospitals
during an additional 10-year period. Because serum phosphorus
had been removed from the laboratory’s automated multichannel
panel during this time, there were many fewer patients in whom
serum phosphorus levels were available (10 dyads from 6 patients).
Nonetheless, even in this much smaller sample, the significant
inverse linear relation between body temperature and serum
phosphorus persisted, with a remarkably similar correlation
(r=20.67, P,0.0001).
Possible adverse effects of hypophosphatemia
Because hypophosphatemia can cause hemolysis and rhabdomy-
olysis [1–3], we compared hematocrit and levels of hemoglobin,
lactic dehydrogenase, indirect bilirubin, and aminotransferase in
those with and without low serum phosphorus (Table 1). We found
no significant difference in these values between the low and
normal phosphorus groups and no correlation between these
laboratory parameters and serum phosphorus level (P$0.15).
Results of chart reviews
Hypophosphatemia was not explained by other factors known to
influence serum phosphorus, including carbohydrate, antacid or
electrolyte administration, alcoholism or diabetes. There was no
evidence for malabsorption, poor oral intake, conditions associated
with enhanced renal excretion of phosphorus or conditions
associated with intracellular phosphorus shifts such as respiratory
alkalosis or carbohydrate administration.
DISCUSSION
Elevated body temperature is not listed as a cause of hypophos-
phatemia in reviews of this topic [1–3], nor has a linear relation
between body temperature and serum phosphorus been reported
previously. However, hypophosphatemia has been observed
consistently in patients with conditions characterized by fever
(altered hypothalamic set point) or hyperthermia (inability to
dissipate a heat load), suggesting that the correlation between
body temperature and serum phosphorus may not be unique to
malaria. Whether the hypophosphatemia observed in these
conditions is linearly related to body temperature has not been
studied.
Indeed, hypophosphatemia has been observed in every
experimental or pathologic condition associated with an increase
in body temperature in which serum phosphorus has been
reported; in both animals [8–13] and in humans [4–6,14–29].
Hypophosphatemia has been reported in patients with fever
from infection [bacteremia and sepsis [14–15], bacterial
pneumonia [16], Legionnaire’s disease [17], toxic shock
syndrome [18], and malaria [4–6]]; in patients with fever from
non-infectious causes [trauma, post operative, burns, and
pancreatitis [19], drug fever [20]]; in volunteers undergoing
experimental hyperthermia [21–22]; in patients receiving ther-
apeutic hyperthermia [23–25]; in patients with accidental
hyperthermia (heat stroke) [26]; during recovery from hypother-
mia [27]; and in patients with neuroleptic malignant syndrome
[28] and Reye’s syndrome [29]. If the association between body
temperature and serum phosphorus levels is causal, and not
restricted to patients with malaria, then this would provide a
unifying explanation for the hypophosphatemia seen in these
otherwise unrelated conditions.
There are three major causes of hypophosphatemia [1,2]:
redistribution of phosphorus from the extracellular fluid into cells,
decreased intestinal absorption of phosphorus, and increased
urinary phosphorus excretion. Our patients were young and
previously healthy. None had renal or gastrointestinal disease,
alcoholism, or other conditions, such as respiratory alkalosis or
carbohydrate administration, that are known to cause phosphorus
redistribution. The resolution of the hypophosphatemia without
specific therapy was rapid as fever resolved, suggesting that
redistribution of phosphorus between the extracellular and
intracellular compartments may have accounted for the develop-
ment and quick resolution of the hypophosphatemia.
Acute respiratory alkalosis, by increasing intracellular pH,
accelerating glycolysis, and causing phosphorus to shift from the
extracellular to the intracellular compartment [30], can result in
transient hypophosphatemia in normal volunteers [7]. Because
hyperventilation and acute respiratory alkalosis have been
observed in sepsis [31] and in experimental [21,22,32], therapeutic
[23,24] and accidental hyperthermia (heat stroke) [25], this
mechanism has been proposed as an explanation for the
hypophosphatemia observed in these conditions [1–3]. In our
patients, however, pH and pCO2 were only minimally altered
even in those with low serum phosphorus levels, and there were no
correlations between serum phosphorus and respiratory rate, pH,
or pCO2. In addition, hypophosphatemia can occur in patients
with bacterial pneumonia without respiratory alkalosis [16], and in
patients undergoing therapeutic hyperthermia even when respira-
tory alkalosis is prevented by control of ventilation [24], suggesting
Figure 2. There was a highly significant correlation (r=20.66,
P,0.002) between changes in serum phosphorus level and changes
in temperature in the 19 patients who had repeated measurements
of both variables. For each 1uC decline in temperature, serum
phosphorus level increased by 0.16 mmol/L [0.51 mg/dL].
doi:10.1371/journal.pone.0001380.g002
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the observed hypophosphatemia.
Carbohydrate administration, which can cause hypophospha-
temia by increasing insulin secretion, accelerating glycolysis, and
inducing intracellular shifts of phosphate [1–3,33], is a common
cause of hypophosphatemia in hospitalized patients [34,35]. In our
study, however, glucose levels did not differ between those with
and without hypophosphatemia (see Table 1), and there was no
significant correlation between serum phosphorus and glucose
levels. In addition, blood samples were obtained before intrave-
nous fluids were administered.
There is one report of a transient increase in the renal
fractional excretion of phosphorus in malaria that correlated with
a decrease in serum phosphorus levels; this was proposed as the
mechanism by which malaria causes hypophosphatemia [5].
However, it is not clear that the degree of observed changes in
fractional excretion of phosphorus can account for the
magnitude and rapidity of observed changes in serum phospho-
rus levels. In addition, patients in that study were receiving
intravenous therapy with glucose-containing fluids when serum
and urine phosphorus measurements were obtained. Since
carbohydrate administration can cause transient hypophospha-
temia [1–3,33] and volume expansion can increase renal
excretion of phosphorus [1,2,36], it is unclear whether the
increased renal phosphorus excretion was responsible for the
observed hypophosphatemia.
Measurements of urinary phosphorus excretion in patients
undergoing therapeutic hyperthermia—in which transient and
severe hypophosphatemia is common—have yielded conflicting
results. One study reported increased renal excretion of
phosphorus [24], while another reported decreased excretion
[23]; the differences may depend on whether respiratory alkalosis
was induced (decreased excretion) or prevented (increased
excretion). These data suggest that increased renal excretion of
phosphorus is not the primary cause for the hypophosphatemia
observed in these patients, since hypophosphatemia occurred
even when renal phosphorus excretion was decreased. Because
we did not measure urinary phosphorus, we cannot assess
the effects of changes in renal phosphorus excretion in our
patients.
We hypothesize that elevation of body temperature increases
intracellular utilization of phosphate in the glycolytic pathway,
causing phosphorus to shift from the extracellular fluid into cells.
For example, in one study of human volunteers, a 2uC rise in
temperature increased oxygen consumption by 19% [37]; in
another study, the same rise in temperature was accompanied by
a 26% increase in oxygen consumption and a 23% increase in
metabolic rate [38]. In rat cerebral cortex, a 1uC rise in
temperature results in a 5–6% increase in oxygen consumption,
an increase in the tissue to serum glucose ratio, and an increase
in intracellular glucose 6 phosphate [39]. Similarly, rhesus
monkeys infected with Plasmodium coatneyi showed both hypo-
phosphatemia and an increased arteriovenous difference in
glucose concentration, consistent with increased glucose utiliza-
tion [8]. A positive correlation between glucose disposal and oral
temperature (r=0.65, P,0.03) has also been observed in
humans with malaria [40]. Because increases in cellular
metabolism are linearly related to temperature, the higher the
temperature, the greater the expected intracellular shift in
phosphorus.
The correlation between body temperature and serum
phosphorus might be caused by non-thermogenic effects of pro-
inflammatory cytokines, such as interleukin (IL)-1, IL-6, tumor
necrosis factor (TNF)-a, and interferon-c. Increased levels of these
cytokines occur in patients with malaria [6,41–44], other
infectious and non-infectious causes of fever [15,45,46] and
hyperthermia [26]. In one study of patients with sepsis [15],
cytokine levels were inversely related to serum phosphorus,
although their relations with body temperature were not reported.
In mice, injection of IL-1B, IL-6, or TNF-a leads to a significant
fall in serum phosphorus levels [15]. Similarly, severe hypophos-
phatemia was induced by infusion of recombinant TNF in 22
patients with liver metastases [47]. Whether this is a direct effect,
or one that is mediated through a cytokine-induced increase in
body temperature, is not known. This question might be resolved
by studying genetic models (e.g., cyclooxygenase [COX]-2
knockout mice) in which injection of IL-6 does not cause fever
[48]. Indeed, in experimental acute bovine mastitis, both fever
and hypophosphatemia can be prevented by treating animals with
ibuprofen [9].
In our patients, there were no differences in serum levels of
indirect bilirubin, lactic dehydrogenase, hematocrit, hemoglobin,
creatinine, or aminotransferase among patients with and without
hypophosphatemia, suggesting that the hypophosphatemia did not
result in measurable hemolysis or rhabdomyolysis. This is
consistent with other data indicating that intracellular shifts of
phosphate do not cause cellular damage in the absence of chronic
phosphate depletion [1–3].
Limitations
Our study has several limitations. First, our findings, although
validated in two separate samples, are restricted to patients with
malaria. Whether these findings are applicable to patients with
elevated body temperature from other causes remains to be
demonstrated. Second, since nearly all of our patients had P. vivax
malaria, in whom severe parasitemia is rare (and parasite loads
were not available to us). Thus we could not determine whether
the degree of parasitemia affected temperature or phosphate
levels. Third, although we postulate that the major mechanism for
hypophosphatemia in our patients was a temperature-induced
intracellular shift of phosphorus, we did not measure renal
excretion of phosphorus, so we cannot exclude the possibility of
renal loss. Fourth, we did not measure hormones that can affect
serum phosphorus such as parathyroid hormone, Vitamin D, and
the phosphatonins (e.g., fibroblast growth factor 23) [1]. Thus we
cannot comment on the effects of hormonal changes, if any, on the
observed hypophosphatemia. Finally, we used available clinical
data; for example, we did not have information on whether
temperature was measured orally or rectally, and the instruments
used to measure serum phosphate levels likely changed during the
several-year periods of study. However, we did find a strong
correlation between temperature and phosphate levels; had the
data been measured more precisely and accurately, the correlation
would almost certainly have been even stronger and more
significant.
In sum, our study demonstrates a strong inverse linear relation
between body temperature and serum phosphorus level that was
not explained by other factors known to cause hypophosphatemia.
If causal, this association can account for the high prevalence of
hypophosphatemia and the rapid changes in serum phosphorus
levels observed in our patients and in previous studies of patients
with malaria. Because hypophosphatemia has been observed in
other clinical conditions characterized by fever or hyperthermia,
this relation may not be unique to malaria or to the mechanism of
body temperature elevation. Indeed, a direct effect of elevated
temperature may provide a unifying hypothesis to explain the
hypophosphatemia observed in other conditions associated with
hyperthermia or fever. Regardless of its pathogenesis, because
Fever and Hypophosphatemia
PLoS ONE | www.plosone.org 4 December 2007 | Issue 12 | e1380each 1uC rise in temperature was associated with about a
0.18 mmol/L [0.56 mg/dL] reduction in serum phosphorus
levels, knowledge of body temperature is important in evaluating
patients with low serum phosphorus levels. Elevation of body
temperature should be added to the list of possible causes of
hypophosphatemia.
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